Study Group: Oncologists (Germany, France, Italy)

Council Members in this Study Group: 352

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Rossana Berardi, Consultant Medical Oncologist, UNIVERSITA' POLITECNICA DELLE MARCHERossana Berardi

Consultant Medical Oncologist
UNIVERSITA' POLITECNICA DELLE MARCHE
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Rossana Berardi, MD, is a Consultant Medical Oncologist and Lecturer at University Hospital. She is also responsible for the Trial Unit in the Department of Oncology at the Universita Politecnica delle Marche, Italy. Dr. Berardi usually deals with about...

15 news post(s)
Stefan Schreiber

Professor
CHRISTIAN ALBRECHTS UNIVERSITAT ZU KIEL
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Stefan Schreiber, MD, is Professor of Medicine and Gastroenterology at the Christian-Albrechts-University in Germany. Dr. Schreiber is responsible for designing, organizing, and conducting phase IB-III clinical trials of novel drugs for inflammatory bowel...

Federico Cappuzzo

Professor & Director of Medical Oncology
Ospedali Riuniti Livorno
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Federico Cappuzzo, MD, is a Professor and Director of the Department of Medical Oncology at Ospedale Riuniti in Livorno, Italy. His main fields of interests include the treatment of lung cancer and colorectal cancer. Dr. Cappuzzo is involved in the development...

1 news post(s)
Federica Bertolini

Medical Oncologist and Researcher
UNIVERSITA' DEGLI STUDI DI MODENA E REGGIO EMILIA
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Federica Bertolini, MD, is a Medical Oncologist and Researcher in the Division of GI Medical Oncology at Policlinico di Modena at the University Of Modena and Reggio Emilia. Dr. Bertolini has expertise in treatment of all gastro-intestinal tumors such...

Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Physician - Department Chair
  • Director

Related Study Groups

Study Group Name No. Members
Nexavar Prescribers: Oncologists 78
Surgeons who specialize in Transplantation 199
Velcade Prescribers for CML (US) 93
Physicians who Treat Oral Mucositis 74
Urologists (Italy) 23
Psychiatrists (EU) 314
Dermatologists who Treat Psoriasis (EU) 55
Infectious Disease Specialists (EU) 337